GeoVax utilizes two robust core technology platforms:

• Modified Vaccinia Ankara (MVA) for creating vaccines for the prevention of various infectious diseases, and the basis for creating cancer immunotherapies.

• Gene-Directed Enzyme Prodrug Therapy (GDEPT)  for the treatment of solid tumors with an initial focus on advanced head and neck cancer.